Neuronetics (NASDAQ: STIM) reported Q2 EPS of ($0.05), $0.07 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $41.57 million versus the consensus estimate of $40.11 million.

For earnings history and earnings-related data on Neuronetics (STIM) click here.